Trademark: 98257360
Word
OMCLISVI
Status
Pending
Status Code
641
Status Date
Wednesday, June 19, 2024
Serial Number
98257360
Mark Type
4
Filing Date
Monday, November 6, 2023

Trademark Owner History

Classifications
5 Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; Therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes

Trademark Events
Nov 9, 2023
New Application Entered
Dec 4, 2023
New Application Office Supplied Data Entered
Jun 19, 2024
Non-Final Action E-Mailed
Jun 19, 2024
Notification Of Non-Final Action E-Mailed
Sep 19, 2024
Application Extension Granted/Receipt Provided
Sep 19, 2024
Application Extension To Response Period - Received
Jun 19, 2024
Non-Final Action Written
Jun 14, 2024
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24